Semin Urol 1995 May;13(2):103-12
Monoclonal antibody imaging of recurrent and metastatic prostate cancer.
Burgers JK, Hinkle GH, Haseman MK.
In summary, this agent is safe for administration and more accurate than any
currently available imaging modality for the detection of extraprostatic
metastases. This agent is still under investigation and some day may aid
urologists in the evaluation of prostate cancer by improving preoperative
staging and demonstration of advanced disease and postoperative localization of
recurrent disease. Improved staging and localization will reduce unnecessary
tests and treatment that will lead to reduced morbidity, better management,
earlier detection, and intervention in advanced disease and improved
cost-effectiveness.
